Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: Sylfirm X Radiofrequency Microneedling for the Treatment of Melasma [NA]

View source ↗

Summary

Clinical trial status update indicates that Sylfirm X radiofrequency microneedling is currently recruiting for melasma treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sylfirm X

Snippet

Sponsor: Benev Company, Inc. | Conditions: Melasma | NA | Status: RECRUITING